Τίτλος:
Curative surgery in highly selected patients with heavily pretreated, relapsed/refractory classical Hodgkin lymphoma
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Papadakis, V.
Efstathopoulou, M.
Angelopoulou, M.K.
Tsourouflis, G.
Prassopoulos, V.
Rondogianni, P.
Kourtesis, A.
Polychronopoulou, S.
Pangalis, G.A.
Vassilakopoulos, T.P.
Περιοδικό:
Clinical Lymphoma Myeloma and Leukemia
Εκδότης:
Taylor and Francis Ltd.
Λέξεις-κλειδιά:
alemtuzumab; bleomycin; carmustine; cisplatin; cyclophosphamide; cytarabine; dacarbazine; doxorubicin; etoposide; gemcitabine; ifosfamide; melphalan; methylprednisolone; prednisolone; prednisone; procarbazine; programmed death 1 ligand 1; rituximab; vinblastine; vincristine; vinorelbine tartrate, adolescent; adult; anaplastic large cell lymphoma; autologous stem cell transplantation; cancer combination chemotherapy; cancer patient; cancer radiotherapy; cancer recurrence; cancer staging; cancer surgery; cancer survival; case report; classical Hodgkin lymphoma; clinical article; clinical practice; disease course; drug megadose; female; follow up; histopathology; human; human tissue; Letter; long term care; lumpectomy; lung adenocarcinoma; lung cancer; male; maximum standardized uptake value; mediastinum; medical history; minimal residual disease; multiple cycle treatment; outcome assessment; overall survival; positron emission tomography-computed tomography; priority journal; recurrent disease; relapse; second cancer; surgical margin; thymoma; thyroid cancer; treatment failure; watchful waiting; Hodgkin disease; nonhodgkin lymphoma, Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin
DOI:
10.1080/10428194.2020.1842404
